Scandion Oncology A/S (STO:SCOL)
Sweden
· Delayed Price · Currency is SEK 0.0190
+0.0016 (9.20%)
Jun 5, 2025, 5:08 PM CET
Scandion Oncology Market Cap
Scandion Oncology has a market cap or net worth of 4.46 million as of June 6, 2025. Its market cap has decreased by -91.02% in one year.
Market Cap
4.46M
Enterprise Value
-14.93M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since January 10, 2020, Scandion Oncology's market cap has decreased from 195.09M to 4.46M, a decrease of -97.71%. That is a compound annual growth rate of -50.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 4.46M | -74.19% |
| Dec 30, 2024 | 17.28M | -89.38% |
| Dec 29, 2023 | 162.62M | 42.68% |
| Dec 30, 2022 | 113.98M | -71.35% |
| Dec 30, 2021 | 397.84M | -37.63% |
| Dec 30, 2020 | 637.89M | 226.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 103.72B |
| Sectra AB | 62.39B |
| Getinge AB | 49.87B |
| Asker Healthcare Group AB | 39.15B |
| Medicover AB | 36.31B |
| Camurus AB | 30.40B |
| AddLife AB | 22.69B |
| Vimian Group AB | 22.06B |